The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the pharmaceutical company Pfizer in 1996 in Kano, Nigeria, during an epidemic of meningococcal meningitis. To test its new antibiotic, trovafloxacin (Trovan), Pfizer gave 100 children trovafloxacin, while another 100 received the gold-standard ...
Jan 1, 2006 ... WLNR 85647918 ("Pfizer Inc.... lashed out Friday at Chinese regulators' recent decision ... J., Aug. 19,2004, at Al. 5. Id. 6. Pfizer filed an appeal of the decision of the China SIPO on September 28, 2004, in the Beijing First Intermediate People's Court. ...... Bruce Einhorn et al., Go East, Big Pharma, Bus. WK.
Feb 17, 2015 ... SOUTHERN DISTRICT OF NEW YORK x. MARY K. JONES, Individually and on Behalf of All Others Similarly Situated,. Plaintiff vs. PFIZER INC., et al,,. Defendants. Civil Action No. I: LO-cv-03864-AKH. CLASS ACTION. NOTICE OF PROPOSED SETTLEMENT OF. CLASS ACTION. EXHIBIT A-i x. 999916 4 ...
In 2001, a group of Nigerian minors and their guardians sued Pfizer in US federal court under the Alien Tort Claims Act (ATCA) alleging that the company violated customary international law by administering Trovan to minors in Kano during the meningitis outbreak. The plaintiffs in Abdullahi v. Pfizer claim that the drug was ...
Apr 2, 2010 ... ... and the jury began deliberating March 24. Judge Patti B. Saris presided. In Re: Neurontin Marketing, Sales Practices, and Products Liability Litigation, MDL Docket No. 1629, No. 04-10981; Guardian Life Insurance Company of America v. Pfizer, Inc., et al., Aetna, Inc., v. Pfizer, Inc., No. 04-10739, D. Mass.
Jun 2, 2014 ... First, PPC contends that Pfizer's literal (or explicit) claim that "[c]linical studies prove" that Listerine is "as effective as floss against plaque and gingivitis" is false. Second, PPC contends that Pfizer's advertisements also implicitly are claiming that Listerine is a replacement for floss — that all the benefits of ...
Jun 30, 2011 ... Allergan, Inc. et. al. v. Athena Cosmetics, Inc. et. al., Case No. 10-1394 (Fed. Cir., May 24, 2011) (Gajarsa, J.). Allergan, a manufacturer of an FDA-approved treatment for inadequate eyelash growth, Latisse®, brought suit alleging the defendants had infringed or induced infringement of multiple patents.
Jeffrey T. Thomas, a partner in the Orange County office of Gibson, Dunn & Crutcher LLP, joined the firm in 1983. A member of the firm's Litigation Department and its IP and Antitrust and Competition Practice Groups, Mr. Thomas has extensive experience in intellectual property, antitrust, unfair competition and general ...
Jan 21, 2010 ... Second Circuit Looks Beyond Complaint To Find State Action Requirement Satisfied.